275 related articles for article (PubMed ID: 1515652)
1. Human breast cancer: survival from first metastasis. Breast Cancer Study Group.
Koenders PG; Beex LV; Kloppenborg PW; Smals AG; Benraad TJ
Breast Cancer Res Treat; 1992; 21(3):173-80. PubMed ID: 1515652
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
[TBL] [Abstract][Full Text] [Related]
3. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptors and prognosis in operable (stage I and II) breast cancer.
Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group.
Koenders PG; Beex LV; Langens R; Kloppenborg PW; Smals AG; Benraad TJ
Breast Cancer Res Treat; 1991 Mar; 18(1):27-32. PubMed ID: 1854977
[TBL] [Abstract][Full Text] [Related]
7. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.
Bardou VJ; Arpino G; Elledge RM; Osborne CK; Clark GM
J Clin Oncol; 2003 May; 21(10):1973-9. PubMed ID: 12743151
[TBL] [Abstract][Full Text] [Related]
9. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
10. Significance of axillary lymph node metastasis in primary breast cancer.
Jatoi I; Hilsenbeck SG; Clark GM; Osborne CK
J Clin Oncol; 1999 Aug; 17(8):2334-40. PubMed ID: 10561295
[TBL] [Abstract][Full Text] [Related]
11. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer.
Nomura Y; Miura S; Koyama H; Enomoto K; Kasumi F; Yamamoto H; Kimura M; Tominaga T; Iino H; Morimoto T
Cancer; 1992 Jan; 69(1):153-64. PubMed ID: 1727658
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and progesterone receptors as prognostic factors in breast cancer.
Brdar B; Graf D; Padovan R; Nola P; Rudan N; Petrinec Z; Sarcević B; Belicza M
Tumori; 1988 Feb; 74(1):45-52. PubMed ID: 3354064
[TBL] [Abstract][Full Text] [Related]
13. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
14. [Effect of various factors on survival after recurrent and/or metastatic breast cancer].
Sevelda P; Kührer I; Zielinski CC; Vavra N; Seifert M; Kubista E; Czerwenka K; Spona J; Salzer H
Geburtshilfe Frauenheilkd; 1991 May; 51(5):387-92. PubMed ID: 1869009
[TBL] [Abstract][Full Text] [Related]
15. Cytosol protein content and prognosis in operable breast cancer. Correlations with steroid hormone receptors and other prognostic factors.
Søreide JA; Lea OA; Kvinnsland S
Breast Cancer Res Treat; 1991 Dec; 20(1):25-32. PubMed ID: 1813067
[TBL] [Abstract][Full Text] [Related]
16. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
Kinoe H; Yamanouchi K; Kuba S; Morita M; Sakimura C; Kanetaka K; Takatsuki M; Abe K; Yano H; Matsumoto M; Otsubo R; Hayashida N; Nagayasu T; Eguchi S
J BUON; 2018 Dec; 23(7):60-66. PubMed ID: 30722113
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
19. 67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer.
Gasparini G; Barbareschi M; Boracchi P; Bevilacqua P; Verderio P; Dalla Palma P; Ménard S
Int J Cancer; 1995 Mar; 60(5):604-10. PubMed ID: 7860133
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
